Inventor · disambiguated record
Cynthia Louise Palmer
Also filed as: PALMER CYNTHIA · PALMER CYNTHIA L · PALMER CYNTHIA LOUISE
40 granted patents·7 pending applications·1,075 citations·filing 1993–2022
98Inventor score
Files withAGOURON PHARMA28PFIZER12AGOURON PHARAMACEUTICALS INC1AGOURON PHARMACETICALS INC1BUNNAGE MARK EDWARD1
Top patents by PatentIndex Score
47 records- 0198US6884890B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted Apr 26, 2005·178 cites·32 claims
- 0298US6534524B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2001·Granted Mar 18, 2003·277 cites·14 claims
- 0396US11220494B2Cyclin dependent kinase inhibitorsPFIZER·Filed 2020·Granted Jan 11, 2022·13 cites·21 claims
- 0496US6531491B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARAMACEUTICALS INC·Filed 2001·Granted Mar 11, 2003·200 cites·10 claims
- 0595US10766884B2Cyclin dependent kinase inhibitorsPFIZER·Filed 2019·Granted Sep 8, 2020·19 cites·20 claims
- 0695US8680111B2Macrocyclic derivatives for the treatment of diseasesPFIZER·Filed 2013·Granted Mar 25, 2014·54 cites·18 claims
- 0793US6635641B2Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2001·Granted Oct 21, 2003·83 cites·11 claims
- 0893US5663131AConveyor lubricants which are compatible with pet containersWEST AGRO INC·Filed 1996·Granted Sep 2, 1997·87 cites·39 claims
- 0991US6891044B2Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 10, 2005·20 cites·43 claims
- 1090US7141587B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2004·Granted Nov 28, 2006·17 cites·9 claims
- 1189US9133215B2Macrocyclic derivatives for the treatment of diseasesPFIZER·Filed 2014·Granted Sep 15, 2015·16 cites·18 claims
- 1286US10662204B2Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agentsPFIZER·Filed 2019·Granted May 26, 2020·4 cites·21 claims
- 1383US8916593B2Alkoxy-substituted 2-aminopyridines as ALK inhibitorsBUNNAGE MARK EDWARD·Filed 2011·Granted Dec 23, 2014·8 cites·5 claims
- 1481US7053107B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 30, 2006·12 cites·4 claims
- 1580US10590115B2Tetrahydroquinazoline derivatives useful as anticancer agentsPFIZER·Filed 2019·Granted Mar 17, 2020·2 cites·14 claims
- 1675US12378232B2Cyclin dependent kinase inhibitorsPFIZER·Filed 2021·Granted Aug 5, 2025·0 cites·2 claims
- 1775US2022324872A1CDK2/4/6 InhibitorsPFIZER·Filed 2022·Application pending·0 cites
- 1874US6869962B2Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their useAGOURON PHARMA·Filed 2003·Granted Mar 22, 2005·6 cites·26 claims
- 1967US11396512B2CDK2/4/6 inhibitorsPFIZER·Filed 2020·Granted Jul 26, 2022·0 cites·12 claims
- 2067US10800783B2CDK2/4/6 inhibitorsPFIZER·Filed 2019·Granted Oct 13, 2020·0 cites·16 claims
- 2167US6525050B1(4-oxo-2-pyrimidinyl)thioalkyl compounds useful as AICARFT inhibitorsAGOURON PHARMA·Filed 1999·Granted Feb 25, 2003·11 cites·4 claims
- 2266US5641774ACompounds useful as antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Jun 24, 1997·6 cites·29 claims
- 2365US6207670B1Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsAGOURON PHARMA·Filed 2000·Granted Mar 27, 2001·1 cites·9 claims
- 2463US7045528B2Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their useAGOURON PHARMA·Filed 2004·Granted May 16, 2006·1 cites·30 claims
- 2560US5739141AAntiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsAGOURON PHARMA·Filed 1993·Granted Apr 14, 1998·9 cites·33 claims
- 2660US2005197492A1Crystal structure of VEGFRKD: ligand complexes and methods of use thereofAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 2758US5594139AProcesses for preparing antiproliferative garft-inhibiting compoundsAGOURON PHARMA·Filed 1994·Granted Jan 14, 1997·7 cites·12 claims
- 2857US7772246B2Pyrazole compounds as RAF inhibitorsPFIZER·Filed 2008·Granted Aug 10, 2010·0 cites·2 claims
- 2955US5804545AStable alkaline chlorine compositionsWEST ARGO INC·Filed 1996·Granted Sep 8, 1998·17 cites·9 claims
- 3054US5726312AMethods for preparing antiproliferative 5-substituted pyrimidone compoundsAGOURON PHARMA·Filed 1995·Granted Mar 10, 1998·7 cites·9 claims
- 3154US2006079548A1Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their useAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 3253US6323210B2Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsAGOURON PHARMA·Filed 2001·Granted Nov 27, 2001·0 cites·4 claims
- 3353US2002173515A1Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsFiled 2001·Application pending·0 cites
- 3452US11203594B2Anti-proliferative agents for treating PAHPFIZER·Filed 2020·Granted Dec 21, 2021·0 cites·30 claims
- 3551US2006160858A1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 3647US5945427AAntiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compoundsAGOURON PHARMA·Filed 1998·Granted Aug 31, 1999·3 cites·33 claims
- 3747US5723607ACompounds useful as antiproliferative agents and GARFT inhibitorsAGOURON PHARMACETICALS INC·Filed 1997·Granted Mar 3, 1998·2 cites·3 claims
- 3847US2004092747A1Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useFiled 2003·Application pending·0 cites
- 3946US5981748ASynthesis of optically pure compounds useful as GARFT inhibitors and their intermediatesAGOURON PHARMA·Filed 1998·Granted Nov 9, 1999·2 cites·13 claims
- 4046US5639749ACompounds useful as antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Jun 17, 1997·3 cites·10 claims
- 4146US5625061ACompounds useful in preparing antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Apr 29, 1997·3 cites·8 claims
- 4245US5639747ACompounds useful as antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Jun 17, 1997·1 cites·48 claims
- 4340US5831100ASyntheses of optically pure compounds useful as GARFT inhibitors and their intermediatesAGOURON PHARMA·Filed 1995·Granted Nov 3, 1998·1 cites·1 claims
- 4439US5641771ACompounds useful as antiproliferative agents and garft inhibitorsAGOURON PHARMA·Filed 1995·Granted Jun 24, 1997·1 cites·10 claims
- 4539US5610319ACompound useful as antiproliferative agents and GARFT inhibitorsAGOURON PHARMA·Filed 1995·Granted Mar 11, 1997·1 cites·12 claims
- 4639US2006160863A1Polymorphic and amorphous forms of 2-{3-[(E)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-N-(4-hydroxy-but-2-ynyl)benzamideAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 4737US5574039AAntiproliferative compounds having nitrogen-containing tricyclic ring systems and phenyl substituentsAGOURON PHARMA·Filed 1994·Granted Nov 12, 1996·3 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →